Skip to main content
. 2021 Apr 19;39(21):2339–2349. doi: 10.1200/JCO.21.00174

FIG 3.

FIG 3.

Kaplan-Meier estimates of PFS2 for each treatment group, with censoring of data at the time of last contact for patients alive without receiving second-line therapy, stopping second-line therapy without disease progression, and not initiating third-line therapy. Tick marks indicate censoring times. HR, hazard ratio; PFS, progression-free survival.